• Skip to primary navigation
  • Skip to main content
Logo
Open search bar
  • About
    • Meet the Team
    • Why Choose Us
  • Services
    • Money Managers
    • Registered Funds
    • Private Equity
    • Broker-Dealers
    • CyberSecure - Funds
  • In The News
  • Outsourced CCO
  • Client Engagement
  • Resources
    • Helpful Information
    • Regulatory Exams
  • Member Content
    • Blog
    • Podcasts & Videos
    • Best Practices
  • Contact Us

Our Take Blog

Home
Our Take Blog
Hedge Fund Portfolio Manager Traded on Material Nonpublic Information about Drug’s Clinical Trials

Hedge Fund Portfolio Manager Traded on Material Nonpublic Information about Drug’s Clinical Trials

  A hedge fund portfolio manager was barred from the industry and sentenced to 9 years in prison for insider trading on behalf of the funds he managed.  The SEC alleges that the portfolio manager developed a relationship, through an expert network firm, with a doctor involved with …

 

A hedge fund portfolio manager was barred from the industry and sentenced to 9 years in prison for insider trading on behalf of the funds he managed.  The SEC alleges that the portfolio manager developed a relationship, through an expert network firm, with a doctor involved with a drug’s clinical trials, thereby giving him access to material nonpublic information.  The doctor provided the hedge fund manager with negative information about impending clinical trial results, which caused the portfolio manager to sell the securities of the two pharmaceutical firms developing the drug.  The funds made $275 Million in profits or avoided losses, and the PM received a $9.3 Million bonus.

 

Our Take

 

Any pecuniary benefit from misusing material nonpublic information can and will result in criminal and civil penalties.  The SEC need not allege that the perpetrator directly benefited by trading for his or her own account. 

Back to Top
logo
480 E. Swedesford Road, Suite 220, Wayne, PA 19087
610-687-5320
LinkedIn Twitter
© 2020 Marlivia Properties LLC